Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China; Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Zhongshan Hospital Institute for Clinical Science, Shanghai Medical College, Fudan University, Shanghai, China; Shanghai Engineering Research Center of AI Technology for Cardiopulmonary Disease, Shanghai, China.
Department of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cancer Lett. 2020 Jan 1;468:82-87. doi: 10.1016/j.canlet.2019.10.009. Epub 2019 Oct 7.
Lung cancer is a heterogeneous disease that is impacted by environmental exposures and by constitutional genetic or epigenetic susceptibilities to disease development and progression. The United States and China have distinct and diverse populations and geographic environmental exposures that contribute to unique patterns of lung cancer incidence and mortality. In this paper, the authors compare trends of incidence and mortality of lung cancer in the US and China, and the impact on lung cancer screening programs in the two countries. It is worth noting that the mortality of lung cancer in the US has decreased gradually while in China it is still increasing over recent years. While decreasing smoking prevalence and the impact of clean air legislation have helped to mitigate the trend in the US relative to China, the increasingly widespread implementation of lung cancer chest CT screening is expected to impact lung cancer incidence and mortality in both countries. Currently there are few studies to compare the environmental and genetic risk factors for US and Chinese populations with regards to lung cancer incidence and mortality. The authors discuss the impact of gender and exposure risks, mainly smoking and environmental pollutants. Of high importance is the incidence of lung cancer in never smokers that is significantly higher in China than in the United States; this is particularly notable in women. These data suggest inclusion of ambient air pollution exposure and gender into lung cancer risk prognostic models to better capture high-risk individuals, especially for non-smoking women.
肺癌是一种异质性疾病,受到环境暴露和个体对疾病发展和进展的遗传或表观遗传易感性的影响。美国和中国拥有不同的人群和地理环境暴露,这导致了两国肺癌发病率和死亡率的独特模式。本文作者比较了美国和中国肺癌发病率和死亡率的趋势,以及这对两国肺癌筛查计划的影响。值得注意的是,近年来,美国肺癌的死亡率逐渐下降,而中国的肺癌死亡率仍在上升。虽然吸烟率的下降和清洁空气法规的影响有助于减轻美国与中国相比的趋势,但越来越广泛地实施肺癌胸部 CT 筛查预计将影响两国的肺癌发病率和死亡率。目前,关于美国和中国人群肺癌发病率和死亡率的环境和遗传风险因素比较研究较少。作者讨论了性别和暴露风险(主要是吸烟和环境污染物)的影响。非常重要的是,从不吸烟者的肺癌发病率在中国显著高于美国;这在女性中尤为明显。这些数据表明,需要将环境空气污染暴露和性别纳入肺癌风险预测模型,以更好地捕捉高危人群,尤其是不吸烟的女性。
Cancer Res. 2021-3-15
Cancer Epidemiol Biomarkers Prev. 2020-2
AJR Am J Roentgenol. 2011-2
Zhonghua Zhong Liu Za Zhi. 2014-7
Am J Respir Crit Care Med. 2015-1-1
Cancer Genomics Proteomics. 2025-6-26
Transl Cancer Res. 2025-4-30